Beyond the Blade: How Vero Orthopaedics Built a Scalable Laser Therapy Program

• Laser Therapy as a Complement, Not Replacement 
  
  • The MLS (Multiwave Locked System) Class IV laser was introduced not to replace surgery but to offer a non-invasive option to reduce pain and inflammation, used both to delay surgery and enhance post-operative recovery. 

• Clinical Use Cases and Protocols
  • Laser therapy was found to be effective for: 

• • • Chronic and acute pain
    • Sports injuries and sprains
    • Arthritis management
    • Post-surgical recovery
    • Neuropathy, including diabetic neuropathy treatment protocols, were standardized, e.g., 6–10 sessions spaced over 2–3 weeks depending on the condition. 

• Building Physician Buy-In 
  
  • Initial skepticism was addressed through:
    • Personal success stories (e.g., a physician and a physician’s wife experienced relief)
    • Hosting demo days where staff and physicians trialed the treatment.
    • 20 of 25 demo participants reported improvement, helping drive early momentum. 

• Operational Workflow Design 
  
  • Vero restricted referrals to internal physicians to ensure clinical appropriateness. Key process elements included:
    • A pre-treatment checklist to flag contraindications.
    • A "spa-like" treatment room for a premium patient experience.
    • A designated tech (typically an MA) trained by the vendor to run sessions and manage patient flow, billing, and scheduling. 

• Financial Model and Incentives
  • The laser program was self-pay and not subject to ancillary service guidelines. Financials were structured to encourage physician referrals:
    • 80% of revenue went to the referring physician.
    • 20% to the practice for overhead.
    • Packages were priced starting around $100 per session, with discounts for multiple body areas. 

• Rapid ROI and Growth 
  • The first laser was paid off within five months due to high demand.
  • A second unit was added within eight months.
  • The program broke even quickly, even with limited marketing—growth was mostly referral-driven. 

• Sustained Patient Satisfaction 
  
  • Approximately 85% of patients reported meaningful relief. Repeat package purchases and requests for treatment on additional body parts affirmed consistent outcomes. Even potential placebo effects were valued if they translated to perceived patient benefit. 

• Practical Lessons and Scaling Tips
  • Use early revenue reports to motivate broader provider participation.
  • Create structured orders and workflows to integrate into clinical practice.
  • Consider initial free sessions to generate awareness and trial.
  • Vet your laser vendor thoroughly; prior positive experiences influenced Vero’s choice. 

Conclusion: 

Vero Orthopedics demonstrated a replicable model for integrating laser therapy as a cash-based service line. By combining strategic buy-in, strong clinical protocols, and efficient operations, the practice not only enhanced patient care options but also created a new revenue stream. For other practices considering similar innovations, this session offers clear, actionable insights.